Loading clinical trials...

Calcium-phosphate Complications Induced by IV Iron Supplementation in Patients With Rendu-Osler Disease | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05544669

Calcium-phosphate Complications Induced by IV Iron Supplementation in Patients With Rendu-Osler Disease

Hypophosphatemia induced by treatments with injectable iron is a frequent side effect already reported during marketing. Situations of osteomalacia secondary to these hypophosphatemias are rarer and r...

Lead sponsor: University Hospital, Strasbourg, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Murielle RONDEAU-LUTZ, MD

CONTACT

33 3 69 55 10 13 [email protected]

Related studies

COMPLETEDNA

Diagnostic Value of Ultra-low Dose Thoracic Scanner for the Pulmonary Arteriovenous Malformation Detection in HHT Patient

NCT04108052 · Telangiectasia, Hereditary Hemorrhagic, Rendu Osler Disease

COMPLETEDPhase 1

The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia

NCT01507480 · Rendu Osler Disease, Telangiectasia, Hereditary Hemorrhagic

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 19, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment220

Start dateAug 2022

Last updatedDec 19, 2023

Condition

Rendu Osler Disease

Locations shown

Service de Médecine interne - CHU de Strasbourg - France

Strasbourg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions